Prospective Survival Analysis — Forward-Looking Time-to-Event Study
Prospective Survival Analysis · Also known as: prospective time-to-event analysis, prospective failure-time analysis, forward-looking survival study, prospective event-time study
Prospective survival analysis is a longitudinal study design in which participants are enrolled before the event of interest occurs, followed forward in time under standardised conditions, and analysed using survival-analytic methods to estimate the time until a defined clinical endpoint — such as death, disease recurrence, or treatment failure. Because data are collected prospectively, exposure and covariate information are recorded before outcomes are known, substantially reducing recall and selection bias relative to retrospective approaches.
Read the full method
Sign in with a free account to read this section.
Method map
The neighbourhood of related methods — select a node to explore.
When to use it
Use prospective survival analysis when you need high-quality, low-bias time-to-event estimates and the study question involves a definable starting point and a discrete endpoint occurring over a meaningful follow-up period. It is the preferred design when exposure or treatment assignment can be recorded before outcomes occur, when the event is rare enough to require active follow-up rather than cross-sectional ascertainment, and when covariate values may change over time and must be captured at each measurement occasion. Do not use this design when the event is common and occurs rapidly (a cross-sectional or case-control design is more efficient), when the required follow-up is too long to be feasible or affordable, or when only historical records are available — in those cases a retrospective survival analysis on existing registry or medical record data is more practical.
Strengths & limitations
- Baseline exposures and covariates are measured before outcomes occur, eliminating recall bias and reducing information bias.
- Time-varying covariates can be captured accurately at each follow-up visit, enabling more realistic hazard models.
- The temporal sequence of exposure preceding outcome is directly observable, strengthening causal inference relative to retrospective designs.
- Censoring mechanisms are explicitly planned and documented, making the censoring-at-random assumption more credible.
- Results are directly interpretable as prospective risk: the probability or hazard of the event under real or experimental conditions.
- Requires substantial time and resources: long follow-up periods, repeated participant contact, and data management infrastructure.
- Loss to follow-up introduces potential selection bias; even moderate dropout rates can undermine the integrity of survival estimates.
- Rare events require large sample sizes to achieve adequate statistical power, making small prospective survival studies underpowered.
- Ethical and logistical constraints may prevent randomised allocation to harmful exposures, limiting causal conclusions to observational comparisons.
Frequently asked
What distinguishes prospective from retrospective survival analysis?
In prospective survival analysis, participants are enrolled before the outcome occurs and followed forward in time with data collected at pre-specified intervals. In retrospective survival analysis, outcomes and covariates are extracted from existing records after events have already occurred. Prospective designs reduce recall and selection bias but require longer timelines and greater resources.
How do I handle participants who are lost to follow-up?
Standard survival analysis treats loss to follow-up as non-informative censoring — the participant is censored at the date of last known contact. If dropout is likely related to prognosis (informative censoring), report a sensitivity analysis using inverse probability of censoring weighting (IPCW) or multiple imputation to assess how much results might change under plausible dropout mechanisms.
How large a sample do I need?
Sample size is determined by the expected number of events, not the number of participants. A common rule of thumb requires at least 10 events per covariate in a Cox model. For log-rank comparisons, standard formulas (e.g., Schoenfeld's method) use the expected event rate, median survival times in each group, and the desired power and alpha level. Simulate your follow-up process to account for dropout.
Can I use prospective survival analysis when there are competing risks?
Yes, and it is important to do so when competing events prevent the primary event from occurring. For example, patients may die from causes other than the disease of interest before experiencing a disease-specific event. In these cases, report cause-specific hazard functions and the cumulative incidence function (Fine-Gray model) alongside standard Kaplan-Meier estimates, which overestimate the true incidence in the presence of competing risks.
When should I use restricted mean survival time (RMST) instead of median survival?
Use RMST when the survival curves do not reach 50% within the observation window (so median survival cannot be computed), when the proportional hazards assumption is violated (so a single hazard ratio is misleading), or when you need an absolute time-based summary that is clinically intuitive. RMST is the average event-free time up to a chosen horizon and is always estimable regardless of how many events occurred.
Sources
- Kleinbaum, D. G., & Klein, M. (2012). Survival Analysis: A Self-Learning Text (3rd ed.). Springer. ISBN: 978-1441966452
- Collett, D. (2015). Modelling Survival Data in Medical Research (3rd ed.). CRC Press. ISBN: 978-1439856789
How to cite this page
ScholarGate. (2026, June 3). Prospective Survival Analysis. ScholarGate. https://scholargate.app/en/epidemiology/prospective-survival-analysis
Which method?
Set this method beside its closest kin and read them side by side — the library lays the books on the table; the choice is yours.
- Cox proportional hazardsEpidemiology↔ compare
- Kaplan-Meier AnalysisEpidemiology↔ compare
- Prospective Cohort StudyEpidemiology↔ compare
- Randomized clinical trialEpidemiology↔ compare
- Survival AnalysisResearch Statistics↔ compare